Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia (2006)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Unidade: FMRP
- Subjects: CANNABIS (EFEITOS); ANSIEDADE (TRATAMENTO); ESQUIZOFRENIA
- Language: Inglês
- Imprenta:
- Publisher: Studium Press
- Publisher place: Houston
- Date published: 2006
- ISBN: 0-9656038-5-7
- Source:
- Título do periódico: Recent progress in medicinal plants: biopharmaceuticals
-
ABNT
ZUARDI, Antonio Waldo; CRIPPA, José Alexandre de Souza; HALLAK, Jaime Eduardo Cecílio; et al. Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. In: Recent progress in medicinal plants: biopharmaceuticals[S.l: s.n.], 2006. -
APA
Zuardi, A. W., Crippa, J. A. de S., Hallak, J. E. C., Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006). Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. In Recent progress in medicinal plants: biopharmaceuticals. Houston: Studium Press. -
NLM
Zuardi AW, Crippa JA de S, Hallak JEC, Moreira FA, Aguiar DC, Guimarães FS. Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. In: Recent progress in medicinal plants: biopharmaceuticals. Houston: Studium Press; 2006. -
Vancouver
Zuardi AW, Crippa JA de S, Hallak JEC, Moreira FA, Aguiar DC, Guimarães FS. Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. In: Recent progress in medicinal plants: biopharmaceuticals. Houston: Studium Press; 2006. - Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
